Articles related to CHRONIC DISEASE MANAGEMENT

A consumer health explainer reviews hydration and blood pressure, including general beverage-intake estimates and cautions for heart failure and kidney disease. It identifies no established daily water target specifically for blood pressure control.

The 2026 ESC heart failure guidelines redefine ejection-fraction phenotypes, formalize stages A through D, and broaden foundational therapy recommendations, including SGLT2 inhibitors and mineralocorticoid receptor antagonists across defined clinical settings.

Updated AAN and AHS guidance outlines when to initiate preventive migraine therapy, how to select treatments based on efficacy and tolerability, and how to tailor management for special populations and comorbidities.

Invasive pneumococcal disease declined among US children across vaccine eras, but incidence remained substantially higher among those with chronic medical or immunocompromising conditions, with relative disparities widening over the 25-year claims-based study.

A Medicare-based analysis found substantial geographic variation in access to board-certified neuromuscular physicians for patients with myasthenia gravis, with specialist growth failing to fully offset regional disparities despite increases in both workforce size and disease prevalence.

Two long-term proton pump inhibitor users presented with severe macrocytic anemia, markedly elevated LDH, and low haptoglobin suggestive of hemolysis. Further evaluation identified combined vitamin B12 and folate deficiency, highlighting a diagnostic mimic of true hemolytic anemia.